Abstract
Objectives:
The relationships between the triglyceride-glucose (TyG) index, TyG-related parameters of different obesity phenotypes and the risk of type 2 diabetes (T2D) remain unclear. We aimed to determine associations between TyG index, obesity-related TyG parameters and T2D risk in Chinese adults.
Methods:
This cross-sectional study included 9489 participants aged ≥40 years from a large scale, community-based cohort study. Multivariable logistic regression was performed to estimate odds ratios (ORs) and 95% confidence intervals (CIs). The receiver operating characteristic (ROC) curve was employed to test and compare the predictive power of obesity-related TyG parameters across different phenotypes for the risk of T2D.
Results:
A total of 2081 (21.9%) participants with T2D were identified. When comparing with participants in the bottom quartile of TyG index, a heightened risk of T2D was observed among the highest quartile group, with an adjusted OR of 5.89 (95% CI: 4.98–6.98). Comparable relationships were found between obesity-related TyG indices and T2D, including TyG-waist circumference (TyG-WC), TyG-waist-to-height ratio (TyG-WHtR), TyG-body mass index (TyG-BMI) and TyG-body fat percentage (TyG-BFP). Abdominal obesity-related TyG indices had the highest predictive capability for T2D, with the area under the curve (AUC) was 0.711 (0.697–0.724) for TyG-WHtR and 0.705 (0.691–0.719) for TyG-WC, which was superior to the general obesity-related TyG indices, with the AUC were 0.683 (0.669–0.698) and 0.631 (0.616–0.646) for TyG-BMI and TyG-BFP, respectively.
Conclusions:
Our findings demonstrate a positive associations between TyG index, obesity-related TyG indices and risk of T2D. Abdominal obesity-related TyG indices had a better predictive value to diabetes than general obesity-related TyG indices.
1 Introduction
Diabetes stands as a prominent contributor to blindness, kidney failure, lower limb amputation and cerebrovascular accidents (). It is estimated that 537 million adults suffer from diabetes in 2021, which is predicted to reach 783 million by 2045 (). Type 2 diabetes (T2D) represents more than 95% of all diabetes cases. Interfering factors such as lifestyle, obesity, metabolic disorders are known to be recognized as key determinants of risks of T2D (). Despite this, exploration into complex metabolism-related biomarkers on the risk of T2D has been limited.
Insulin resistance is the critical pathophysiological basic in development of T2D. The triglyceride-glucose (TyG) index, derived from the product of triglyceride (TG) and fasting plasma glucose (FPG) concentrations, has emerged as a non-insulin-based marker of insulin resistance in several studies (–). Given the widespread availability of TG testing compared to insulin, the TyG index may be a more convenient and practical method to assess insulin resistance in clinical practice (), in comparison with the traditional indicator of homeostatic model assessment of insulin resistance (HOMA-IR) calculated using insulin and FPG levels. Furthermore, TyG index exhibit superior sensitivity in detecting insulin resistance in Chinese T2D patients compared to HOMA-IR (). Associations between TyG index and prediabetes and T2D risk have been identified in previous studies (, , ). However, the robustness of TyG index and its-related indices remains controversial in the current studies (–).
Obesity is another modifiable and major cause for T2D, which usually interacts with other risk factors to elevate the risk of chronic conditions. Obesity could be categorized into general and abdominal adiposity, commonly characterized by body mass index (BMI), body fat percentage (BFP), waist circumference (WC), or waist-to-height ratio (WHtR). The latest research has demonstrated that general and abdominal obesity could discriminate people with or without hypertension (). Abdominal obesity may pose a more important risk for pancreatic cancer compared to general adiposity (). All of these suggests the differential impacts of distinct phenotypes of obesity on diseases outcomes. The existing studies have explored the relationships between TyG-BMI, TyG-WC, TyG-WHtR and T2D (–), but few of them were engaged in the interaction of TyG index and BFP on T2D.
Therefore, the present study aimed to examine the relationship between TyG index, as well as obesity-related TyG indices, and the risk of T2D within a substantial sample size of middle-aged and elderly population in Chinese community.
2 Methods
2.1 Study population
A cross-sectional design was undertaken in a community in Guangzhou, China, utilizing a subgroup of participants from the Risk Evaluation of cAncers in Chinese diabeTic Individuals: A lONgitudinal (REACTION) study, which was established as a multicenter prospective cohort to assess diabetes and cancer in the Chinese population. Detailed protocols of this study have been reported previously (, ). In short, a total of 10,104 residents aged ≥ 40 years were recruited via examination notices or home visits from June to November 2011, among which 9,916 signed written informed consent to participate. Study protocol was approved by the Ethical Committee of Sun Yat-sen Memorial Hospital of Sun Yat-sen University and Ruijin Hospital Ethics Committee of Shanghai Jiao Tong University School of Medicine with an approval number of 14 on March 10, 2011, and adhered to the declaration of Helsinki and its later amendments.
For the current analysis, participants were further excluded if they had no measurement data of FPG (n = 13), TG (n = 29), oral glucose tolerance test 2 h plasma glucose (OGTT 2h-PG, n = 68), glycated hemoglobin (HbA1c, n = 39), height or weight, (n = 200), and WC (n = 78). Finally, 9,489 eligible individuals were included in the present analysis, with 8,396 having undergone body fat assessment and obtained BFP measurements (Figure 1).
Figure 1
2.2 Sociodemographic data collection and anthropometric assessments
A standardized questionnaire was conducted to gather sociodemographic information, lifestyle habits, and medication use. Education levels were categorized as less than high school, high school, and college or above, while occupation was stratified into light, medium and heavy physical labor. Smokers and alcohol drinkers were participants who smoked or drank regularly in the past six months.
Anthropometric measurements were conducted by experienced research personnel using standard procedure. BMI was calculated as weight/height squared (kg/m2), while WHtR was derived using the formula WC/height. Content of body fat was determined using a body fat meter (OMRON HBF-306, Omron Company, China) and BFP was calculated automatically. Blood pressure was recorded using the automated electronic device (OMRON, Omron Company, China). Individuals with elevated blood pressure (systolic ≥ 140 mmHg or diastolic ≥ 90 mmHg), self-reported diagnosis of hypertension by a clinician, or prescribed antihypertensive drugs were considered to existence of hypertension.
2.3 Blood sample collection and laboratory measurements
With a minimum of 10 hours of overnight fasting, peripheral venous blood was collected for laboratory analysis. FPG, fasting serum insulin (FINS), TG, total cholesterol (TC), high-density lipoprotein cholesterol (HDL-C), low-density lipoprotein cholesterol (LDL-C) were determined using the autoanalyzer (Beckman CX-7 Biochemical Autoanalyzer, Brea, CA, USA). HbA1c was measured by high-performance liquid chromatography (Bio-Rad, Hercules, CA). OGTT was carried out according to standard procedure and OGTT 2h-PG was determined. TyG index and obesity-related TyG indices were defined as described previously (, ): TyG = ln (TG [mg/dL] × FPG [mg/dL]/2), TyG-BMI = TyG × BMI, TyG-WC = TyG × WC, TyG-WHtR = TyG × WHtR, TyG-BFP = TyG × BFP.
2.4 Outcome definition
T2D was defined () if any of the following conditions was met: (1) FPG ≥7.0 mmol/L, (2) OGTT 2h-PG ≥11.1 mmol/L, (3) HbA1c ≥ 6.5%, (4) a self-reported diagnosis of diabetes by a clinician, (5)the use of diabetic medications, including insulin. Prediabetes was defined as the existence of one of the following: (1) concentrations of FPG were between 6.1 mmol/L and 7.0 mmol/L, (2) concentrations of OGTT 2h-PG were between 7.8 mmol/L and 11.1 mmol/L, (3) HbA1c was between 5.7% and 6.5%. Impaired glucose metabolism encompassed the presence of either T2D or prediabetes.
2.5 Statistical analysis
Participants were clustered into fours groups based on quartiles of TyG index. Continuous variables were described as mean and standard deviation (SD), whereas categorical variables were summarized by counts and frequencies, respectively. Comparisons of basic characteristics, including demographic, anthropometric, lifestyles, diseases information and laboratory measurements across TyG index quartiles, were conducted via one-way ANOVA, Kruskal-Wallis tests or Pearson’s Chi-Squared tests as appropriate.
Logistic regression was employed to investigate the relationship between both TyG index and obesity-related TyG indices (including TyG-BMI, TyG-WC, TyG-WHtR, and TyG-BFP), and T2D risk without adjustment in model 1. Model 2 adjusted for non-modifiable factors including sex (men, women) and age (continuous). Model 3 further adjusted for modifiable risk factors of T2D, including education levels (categorized as mentioned above), occupation (categorized as mentioned above), smoking (smoker, non-smoker), alcohol drinking (alcohol drinker, non-alcohol drinker) and BMI (continuous). Odds ratios (ORs) and 95% confidence intervals (CIs) were calculated, with the lowest quartile serving as the reference. Linear trends were assessed by replacing quartiles of TyG index with median values within subgroups and assigning as continuous variables in the models. Linear regression was also conducted to assess relationships between TyG index, obesity-related TyG-parameters, and indicators of glucose metabolism without and with adjustment for potential covariates mentioned above. Stratified analysis was performed to explore whether the correction between TyG index quartiles and T2D risk varied among subjects with different characteristics, with interactions estimated by including multiplicative interaction terms. The receiver operating characteristic (ROC) curve was performed to assess the predictive capability of TyG index and obesity-related TyG indices for T2D risk. Pearson’s Correlation analysis was conducted to explore relationships among TyG index and obesity-related TyG indices. All of the correlation coefficients calculated were greater than 0.4, indicating moderate to strong positive correlations among them (Supplementary Table S1). Missing covariates data were handled through the multiple imputation method.
All statistical analyses were performed using R 4.4.2 and were two-sided. P < 0.05 was considered statistically significant.
3 Results
3.1 Basic characteristics
Of the 9,489 study participants, there were 2,692 (28.4%) men and 6,797 (71.6%) women. Mean age was 56.0 ± 8.0 years. Table 1 listed the basic characteristics of participants stratified by quartiles of TyG index. Participants in the highest quartile were older, had higher BMI, BFP, WC and blood pressure, high levels of FPG, OGTT 2h-PG, HbA1c, FINS, TC, TG and LDL-C, had lower education levels and lower HDL-C levels (all P < 0.001, all P-trend < 0.001) compared to those in the lowest quartile. Participants in the higher quartiles of TyG index tended to be men, smokers, and had high prevalence of T2D, impaired glucose metabolism and hypertension (all P < 0.001, all P-trend < 0.001). No significant differences were noted in alcohol drinking status among participants with various quartiles of TyG index (P = 0.937, P-trend = 0.924).
Table 1
| Characteristics | Total | Quartiles of TyG index | P | P-trend | |||
|---|---|---|---|---|---|---|---|
| Q1 (n = 2505) | Q2 (n = 2501) | Q3 (n = 2498) | Q4 (n = 2501) | ||||
| Range of TyG index | 6.16–12.07 | ≤8.70 | 8.27–8.63 | 8.64–9.04 | ≥9.05 | <0.001 | <0.001 |
| Mean of TyG index | 8.69 ± 0.61 | 7.99 ± 0.24 | 8.45 ± 0.10 | 8.82 ± 0.12 | 9.50 ± 0.43 | ||
| Age, years | 56.0 ± 8.0 | 54.0 ± 7.7 | 55.7 ± 7.7 | 56.7 ± 7.9 | 57.5 ± 8.0 | <0.001 | <0.001 |
| Sex, n (%) | <0.001 | <0.001 | |||||
| Men | 2692 (28.4) | 563 (23.5) | 615 (25.9) | 681 (28.9) | 833 (35.4) | ||
| Women | 6797 (71.6) | 1835 (76.5) | 1763 (74.1) | 1677 (71.1) | 1522 (64.6) | ||
| Occupation, n (%) | <0.001 | <0.001 | |||||
| Light labor | 6999 (73.8) | 1672 (69.7) | 1751 (73.6) | 1784 (75.7) | 1792 (76.1) | ||
| Medium labor | 1426 (15.0) | 444 (18.5) | 354 (14.9) | 321 (13.6) | 307 (13.0) | ||
| Heavy labor | 1064 (11.2) | 282 (11.8) | 273 (11.5) | 253 (10.7) | 256 (10.9) | ||
| Education levels, n (%) | <0.001 | <0.001 | |||||
| Less than high school | 3715 (39.2) | 845 (35.2) | 897 (37.7) | 944 (40.0) | 1029 (43.7) | ||
| High school | 4893 (51.6) | 1319 (55.0) | 1266 (53.2) | 1192 (50.6) | 1116 (47.4) | ||
| College or above | 881 (9.3) | 234 (9.8) | 215 (9.0) | 222 (9.4) | 210 (8.9) | ||
| Smoking status, n (%) | <0.001 | <0.001 | |||||
| Non-smoker | 7750 (81.7) | 2038 (85.0) | 1976 (83.1) | 1925 (81.6) | 1811 (76.9) | ||
| Smoker | 1739 (18.3) | 360 (15.0) | 402 (16.9) | 433 (18.4) | 544 (23.1) | ||
| Alcohol drinking status, n (%) | 0.937 | 0.924 | |||||
| Non-alcohol drinker | 6832 (72.0) | 1732 (72.2) | 1700 (71.5) | 1701 (72.1) | 1699 (72.1) | ||
| Alcohol drinker | 2657 (28.0) | 666 (27.8) | 678 (28.5) | 657 (27.9) | 656 (27.9) | ||
| Height, cm | 158.3 ± 7.5 | 158.0 ± 7.3 | 158.1 ± 7.3 | 158.2 ± 7.6 | 159.0 ± 7.9 | <0.001 | <0.001 |
| Weight, kg | 59.3 ± 9.6 | 56.2 ± 8.9 | 57.9 ± 8.9 | 60.2 ± 9.6 | 62.9 ± 9.6 | <0.001 | <0.001 |
| BMI, kg/m2 | 23.6 ± 3.1 | 22.5 ± 3.1 | 23.1 ± 3.0 | 24.0 ± 3.1 | 24.8 ± 2.9 | <0.001 | <0.001 |
| WC, cm | 81.6 ± 9.2 | 77.7 ± 8.7 | 80.1 ± 8.8 | 82.9 ± 8.8 | 85.8 ± 8.3 | <0.001 | <0.001 |
| Hip circumference, cm | 94.0 ± 7.0 | 92.4 ± 6.7 | 93.3 ± 6.9 | 94.5 ± 7.0 | 95.7 ± 7.0 | <0.001 | <0.001 |
| WHtR | 0.52 ± 0.06 | 0.49 ± 0.05 | 0.51 ± 0.06 | 0.52 ± 0.05 | 0.54 ± 0.05 | <0.001 | <0.001 |
| Body fat percentage, % | 29.4 ± 6.0 | 27.9 ± 6.1 | 29.0 ± 6.1 | 30.0 ± 5.8 | 30.5 ± 5.8 | <0.001 | <0.001 |
| SBP, mmHg | 126.1 ± 16.5 | 120.4 ± 15.4 | 124.2 ± 15.6 | 127.4 ± 16.1 | 132.5 ± 16.5 | <0.001 | <0.001 |
| DBP, mmHg | 75.3 ± 9.8 | 72.4 ± 9.6 | 74.3 ± 9.6 | 76.0 ± 9.4 | 78.6 ± 9.6 | <0.001 | <0.001 |
| FPG, mmol/L | 5.7 ± 1.3 | 5.1 ± 0.6 | 5.4 ± 0.7 | 5.7 ± 1.0 | 6.6 ± 2.1 | <0.001 | <0.001 |
| OGTT 2h-PG, mmol/L | 8.1 ± 3.1 | 6.9 ± 2.1 | 7.5 ± 2.3 | 8.3 ± 2.9 | 9.8 ± 3.9 | <0.001 | <0.001 |
| HbA1c, % | 6.0 ± 0.9 | 5.7 ± 0.5 | 5.9 ± 0.5 | 6.0 ± 0.7 | 6.5 ± 1.4 | <0.001 | <0.001 |
| FINS, μU/ml | 8.3 ± 5.8 | 6.2 ± 3.6 | 7.3 ± 5.9 | 8.8 ± 5.1 | 10.9 ± 7.1 | <0.001 | <0.001 |
| TC, mmol/L | 5.2 ± 1.3 | 4.5 ± 1.3 | 5.2 ± 1.1 | 5.5 ± 1.1 | 5.7 ± 1.2 | <0.001 | <0.001 |
| TG, mmol/L | 1.6 ± 1.2 | 0.7 ± 0.2 | 1.1 ± 0.2 | 1.5 ± 0.3 | 3.0 ± 1.7 | <0.001 | <0.001 |
| HDL-C, mmol/L | 1.3 ± 0.4 | 1.4 ± 0.4 | 1.4 ± 0.4 | 1.3 ± 0.3 | 1.2 ± 0.3 | <0.001 | <0.001 |
| LDL-C, mmol/L | 3.1 ± 1.0 | 2.7 ± 0.9 | 3.2 ± 0.9 | 3.4 ± 0.9 | 3.3 ± 1.0 | <0.001 | <0.001 |
| TyG-WC | 710.8 ± 107.6 | 621.2 ± 73.7 | 676.8 ± 75.5 | 731.4 ± 79.8 | 815.9 ± 90.1 | <0.001 | <0.001 |
| TyG-WHtR | 4.49 ± 0.67 | 3.94 ± 0.46 | 4.29 ± 0.48 | 4.63 ± 0.49 | 5.14 ± 0.56 | <0.001 | <0.001 |
| TyG-BMI | 205.6 ± 34.3 | 179.7 ± 25.4 | 195.4 ± 25.8 | 211.9 ± 27.5 | 235.9 ± 30.4 | <0.001 | <0.001 |
| TyG-BFP | 255.5 ± 57.8 | 223.2 ± 50.0 | 245.4 ± 51.4 | 264.7 ± 51.6 | 289.7 ± 56.0 | <0.001 | <0.001 |
| Presence of hypertension, n (%) | <0.001 | <0.001 | |||||
| No | 7525 (79.8) | 2096 (87.9) | 1983 (83.7) | 1842 (78.8) | 1604 (68.5) | ||
| Yes | 1906 (20.2) | 288 (12.1) | 385 (16.3) | 496 (21.2) | 737 (31.5) | ||
| Presence of type 2 diabetes, n (%) | <0.001 | <0.001 | |||||
| No | 7408 (78.1) | 2187 (91.2) | 2049 (86.2) | 1834 (77.8) | 1338 (56.8) | ||
| Yes | 2081 (21.9) | 211 (8.8) | 329 (13.8) | 524 (22.2) | 1017 (43.2) | ||
| Presence of impaired glucose metabolism, n (%) | <0.001 | <0.001 | |||||
| No | 1877 (19.8) | 813 (33.9) | 528 (22.2) | 356 (15.1) | 180 (7.6) | ||
| Yes | 7612 (80.2) | 1585 (66.1) | 1850 (77.8) | 2002 (84.9) | 2175 (92.4) | ||
| Status of glucose metabolism, n (%) | <0.001 | <0.001 | |||||
| Normal | 1877 (19.8) | 813 (33.9) | 528 (22.2) | 356 (15.1) | 180 (7.6) | ||
| Prediabetes | 5531 (58.3) | 1374 (57.3) | 1521 (64.0) | 1478 (62.7) | 1158 (49.2) | ||
| Diabetes | 2081 (21.9) | 211 (8.8) | 329 (13.8) | 524 (22.2) | 1017 (43.2) | ||
Basic characteristics of participants by quartiles of TyG index1.
1 Data are mean ± SD or n (%).
TyG index, triglyceride-glucose index; Q1, first quartile; Q2, second quartile; Q3, third quartile; Q4, fourth quartile; BMI, body mass index; WC, Waist circumference; WHtR, waist-to-height ratio; SBP, systolic blood pressure; DBP, diastolic blood pressure; FPG, fasting plasma glucose; OGTT 2h-PG, oral glucose tolerance test 2 h plasma glucose; HbA1c, glycated hemoglobin; FINS, fasting serum insulin; TC, total cholesterol; TG, triglycerides; HDL-C, high-density lipoprotein cholesterol; LDL-C, low-density lipoprotein cholesterol; WC, waist circumference; BFP, body fat percentage.
3.2 TyG index, obesity-related TyG indices and risk of T2D
Table 2 presented the relationships between TyG index quartiles, obesity-related TyG indices and T2D. As for TyG index, the number of cases of T2D were lowest in the bottom quartile and highest in the fourth quartile of TyG index. A positive correction between TyG index and T2D risk was identified with an unadjusted OR of 7.88 (95% CI: 6.69–9.27, P-trend < 0.001) in the highest quartile in comparison with the first quartile. Multivariable analyses, adjusted for sex and age, revealed an adjusted OR of 7.08 (95% CI: 6.00–8.35, P-trend < 0.001) in the highest TyG index quartile compared to the lowest. This association remained statistically significant after further adjusting for modifiable T2D risk factors, with a fully adjusted OR of 5.89 (95% CI: 4.98–6.98, P-trend < 0.001) in the fourth quartile. When considering TyG index as a continuous variable, the risk of T2D also sharply increased for each SD increment in TyG index, irrespective of potential covariate adjustments (fully adjusted OR = 2.07, 95% CI: 1.96–2.19, P < 0.001). With regard to obesity-related TyG indices, including TyG-BMI, TyG-WC, TyG-WHtR and TyG-BFP, similar findings were noted between obesity-related TyG indices and T2D without or with adjustments for potential covariates (all P-trend < 0.001). Consistent results were also found between TyG index, obesity-related TyG indices and risk of impaired glucose metabolism (Supplementary Table S2).
Table 2
| TyG index | Quartiles of TyG and obesity-related TyG indices | P-trend | Per SD increment | ||||
|---|---|---|---|---|---|---|---|
| Q1 | Q2 | Q3 | Q4 | ||||
| TyG | |||||||
| Case/total, n | 211/2398 | 329/2378 | 524/2358 | 1017/2355 | |||
| Model 11 | 1.00 (ref.) | 1.66 (1.39, 2.00) | 2.96 (2.49, 3.52) | 7.88 (6.69, 9.27) | <0.001 | 2.24 (2.13, 2.37) | <0.001 |
| Model 22 | 1.00 (ref.) | 1.55 (1.29, 1.87) | 2.66 (2.23, 3.16) | 7.08 (6.00, 8.35) | <0.001 | 2.21 (2.09, 2.33) | <0.001 |
| Model 33 | 1.00 (ref.) | 1.47 (1.22, 1.77) | 2.35 (1.97, 2.80) | 5.89 (4.98, 6.98) | <0.001 | 2.07 (1.96, 2.19) | <0.001 |
| Abdominal obesity-related TyG indices | |||||||
| TyG-WC | |||||||
| Case/total, n | 210/2379 | 357/2369 | 563/2378 | 951/2363 | |||
| Model 11 | 1.00 (ref.) | 1.83 (1.53, 2.20) | 3.20 (2.70, 3.80) | 6.96 (5.91, 8.19) | <0.001 | 2.15 (2.04, 2.27) | <0.001 |
| Model 22 | 1.00 (ref.) | 1.78 (1.48, 2.13) | 2.98 (2.51, 3.54) | 6.51 (5.51, 7.71) | <0.001 | 2.13 (2.01, 2.25) | <0.001 |
| Model 33 | 1.00 (ref.) | 1.76 (1.45, 2.12) | 2.93 (2.42, 3.54) | 6.30 (5.11, 7.76) | <0.001 | 2.34 (2.17, 2.52) | <0.001 |
| TyG-WHtR | |||||||
| Case/total, n | 214/2379 | 350/2367 | 529/2372 | 988/2371 | |||
| Model 11 | 1.00 (ref.) | 1.76 (1.47, 2.10) | 2.90 (2.45, 3.44) | 7.23 (6.14, 8.50) | <0.001 | 2.23 (2.11, 2.35) | <0.001 |
| Model 22 | 1.00 (ref.) | 1.64 (1.37, 1.97) | 2.65 (2.23, 3.15) | 6.22 (5.28, 7.34) | <0.001 | 2.11 (2.00, 2.24) | <0.001 |
| Model 33 | 1.00 (ref.) | 1.65 (1.37, 1.99) | 2.67 (2.21, 3.23) | 6.26 (5.09, 7.71) | <0.001 | 2.38 (2.20, 2.57) | <0.001 |
| General obesity-related TyG indices | |||||||
| TyG-BMI | |||||||
| Case/total, n | 237/2381 | 386/2373 | 538/2365 | 920/2370 | |||
| Model 11 | 1.00 (ref.) | 1.76 (1.48, 2.09) | 2.66 (2.26, 3.14) | 5.74 (4.90, 6.72) | <0.001 | 1.98 (1.88, 2.08) | <0.001 |
| Model 22 | 1.00 (ref.) | 1.71 (1.44, 2.04) | 2.58 (2.18, 3.05) | 5.63 (4.80, 6.61) | <0.001 | 1.98 (1.88, 2.09) | <0.001 |
| Model 34 | 1.00 (ref.) | 1.71 (1.44, 2.04) | 2.58 (2.18, 3.05) | 5.60 (4.77, 6.57) | <0.001 | 1.98 (1.87, 2.08) | <0.001 |
| TyG-BFP | |||||||
| Case/total, n | 297/2100 | 364/2104 | 424/2103 | 721/2089 | |||
| Model 11 | 1.00 (ref.) | 1.27 (1.07, 1.50) | 1.53 (1.30, 1.80) | 3.20 (2.75, 3.73) | <0.001 | 1.65 (1.56, 1.75) | <0.001 |
| Model 22 | 1.00 (ref.) | 1.48 (1.24, 1.76) | 1.98 (1.66, 2.37) | 4.28 (3.57, 5.13) | <0.001 | 1.86 (1.74, 1.99) | <0.001 |
| Model 33 | 1.00 (ref.) | 1.30 (1.08, 1.55) | 1.58 (1.30, 1.91) | 2.86 (2.30, 3.56) | <0.001 | 1.67 (1.53, 1.83) | <0.001 |
Odds ratios and 95% CIs of T2D by quartiles of TyG and obesity-related TyG indices.
1 Unadjusted. 2 Adjusted for age (continuous) and sex (men, women). 3 Adjusted additionally for education levels (less than high school, high school, college or above), occupation (light, medium, heavy physical labor), smoking status (smoker, non-smoker), alcohol drinking (alcohol drinker, non-alcohol drinker) and BMI (continuous). 4 Adjusted for covariates mentioned above except for BMI.
CI, confidence interval; T2D, type 2 diabetes; TyG index, triglyceride-glucose index; Q1, first quartile; Q2, second quartile; Q3, third quartile; Q4, fourth quartile; SD, standard deviation; WC, waist circumference; WHtR, waist-to-height ratio; BMI, body mass index; BFP, body fat percentage.
3.3 TyG index, obesity-related TyG indices and indicators of glucose metabolism
Linear corrections of TyG index, obesity-related TyG indices with glucose metabolism were shown in Table 3. Positive associations between TyG index and indicators of glucose metabolism, including FPG (β = 0.41, standard error (SE) = 0.01), OGTT 2h-PG (β = 0.85, SE = 0.03) and HbA1c (β = 0.23, SE = 0.01), were found (all P < 0.001), following adjustment for potential confounding factors. As for obesity-related TyG indices, identical positive associations were observed with FPG (β: 0.28–0.41, P < 0.001), OGTT 2h-PG (β: 0.50–0.91, P < 0.001) and HbA1c (β: 0.14–0.24, P < 0.001) after additionally adjusting for potential covariates.
Table 3
| TyG index | Model 11 | Model 22 | Model 33 | ||||||
|---|---|---|---|---|---|---|---|---|---|
| β (95% CI) | SE | P | β (95% CI) | SE | P | β (95% CI) | SE | P | |
| FPG | |||||||||
| TyG | 0.45 (0.42, 0.47) | 0.01 | <0.001 | 0.43 (0.41, 0.45) | 0.01 | <0.001 | 0.41 (0.39, 0.44) | 0.01 | <0.001 |
| TyG-WC | 0.36 (0.34, 0.39) | 0.01 | <0.001 | 0.35 (0.32, 0.37) | 0.01 | <0.001 | 0.41 (0.38, 0.44) | 0.02 | <0.001 |
| TyG-WHtR | 0.36 (0.33, 0.38) | 0.01 | <0.001 | 0.34 (0.32, 0.36) | 0.01 | <0.001 | 0.41 (0.38, 0.44) | 0.02 | <0.001 |
| TyG-BMI | 0.32 (0.29, 0.34) | 0.01 | <0.001 | 0.31 (0.28, 0.33) | 0.01 | <0.001 | 0.30 (0.28, 0.33)4 | 0.01 | <0.001 |
| TyG-BFP | 0.21 (0.18, 0.23) | 0.01 | <0.001 | 0.29 (0.26, 0.32) | 0.02 | <0.001 | 0.28 (0.24, 0.32) | 0.02 | <0.001 |
| OGTT 2h-PG | |||||||||
| TyG | 0.96 (0.91, 1.01) | 0.03 | <0.001 | 0.91 (0.86, 0.96) | 0.03 | <0.001 | 0.85 (0.79, 0.90) | 0.03 | <0.001 |
| TyG-WC | 0.83 (0.77, 0.88) | 0.03 | <0.001 | 0.79 (0.74, 0.85) | 0.03 | <0.001 | 0.86 (0.79, 0.94) | 0.04 | <0.001 |
| TyG-WHtR | 0.87 (0.82, 0.93) | 0.03 | <0.001 | 0.81 (0.75, 0.86) | 0.03 | <0.001 | 0.91 (0.84, 0.98) | 0.04 | <0.001 |
| TyG-BMI | 0.76 (0.70, 0.81) | 0.03 | <0.001 | 0.73 (0.67, 0.78) | 0.03 | <0.001 | 0.72 (0.67, 0.77)4 | 0.03 | <0.001 |
| TyG-BFP | 0.54 (0.48, 0.60) | 0.03 | <0.001 | 0.62 (0.55, 0.68) | 0.03 | <0.001 | 0.50 (0.42, 0.58) | 0.04 | <0.001 |
| HbA1c | |||||||||
| TyG | 0.26 (0.24, 0.27) | 0.01 | <0.001 | 0.24 (0.23, 0.26) | 0.01 | <0.001 | 0.23 (0.21, 0.24) | 0.01 | <0.001 |
| TyG-WC | 0.22 (0.21, 0.24) | 0.01 | <0.001 | 0.21 (0.20, 0.23) | 0.01 | <0.001 | 0.24 (0.21, 0.26) | 0.01 | <0.001 |
| TyG-WHtR | 0.23 (0.21, 0.24) | 0.01 | <0.001 | 0.21 (0.19, 0.23) | 0.01 | <0.001 | 0.24 (0.22, 0.26) | 0.01 | <0.001 |
| TyG-BMI | 0.20 (0.18, 0.21) | 0.01 | <0.001 | 0.19 (0.17, 0.21) | 0.01 | <0.001 | 0.19 (0.17, 0.20)4 | 0.01 | <0.001 |
| TyG-BFP | 0.14 (0.12, 0.16) | 0.01 | <0.001 | 0.17 (0.15, 0.19) | 0.01 | <0.001 | 0.14 (0.11, 0.16) | 0.01 | <0.001 |
Associations between TyG index, obesity-related TyG indices and indicators of glucose metabolism.
1 Unadjusted. 2 Adjusted for age (continuous) and sex (men, women). 3 Adjusted additionally for education levels (less than high school, high school, college or above), occupation (light, medium, heavy physical labor), smoking status (smoker, non-smoker), alcohol drinking (alcohol drinker, non-alcohol drinker) and BMI (continuous). 4 Adjusted for covariates mentioned above except for BMI.
TyG index, triglyceride-glucose index; Q1, first quartile; Q2, second quartile; Q3, third quartile; Q4, fourth quartile; CI, confidence interval; SE, standard error; FPG, fasting plasma glucose; WC, waist circumference; WHtR, waist-to-height ratio; BMI, body mass index; BFP, body fat percentage; OGTT 2h-PG, oral glucose tolerance test 2 h plasma glucose; HbA1c, glycated hemoglobin.
3.4 Interactions and stratified analyses
Table 4 delineated the influences of TyG index on T2D risk across strata of selected potential risk factors. A statistically significant multiplicative interaction was demonstrated between quartiles of TyG index and sex on associations with T2D risk (P-interaction = 0.024). Stratified by sex, stronger associations of TyG index with T2D risk were found in women (OR = 6.51, 95% CI: 5.32–7.98, P-trend < 0.001) than in men (OR = 4.41, 95% CI: 3.23–6.01, P-trend < 0.001). No notable multiplicative interactions were identified between smoking status, alcohol drinking, different phenotypes of obesity and quartiles of TyG index (all P-interaction > 0.05). The influences of TyG index on risk of impaired glucose metabolism stratified by confounders mentioned above were shown in Supplementary Table S3 and consistent results were found.
Table 4
| TyG index | n | Quartiles of TyG index | P-trend | P-interaction | |||
|---|---|---|---|---|---|---|---|
| Q1 | Q2 | Q3 | Q4 | ||||
| Sex | 0.024 | ||||||
| Men | 2692 | 1.00 | 1.46 (1.04, 2.07) | 2.14 (1.55, 2.97) | 4.41 (3.23, 6.01) | <0.001 | |
| Women | 6797 | 1.00 | 1.45 (1.16, 1.81) | 2.38 (1.93, 2.93) | 6.51 (5.32, 7.98) | <0.001 | |
| Smoking status | 0.058 | ||||||
| Non-smoker | 7750 | 1.00 | 1.42 (1.15, 1.74) | 2.40 (1.97, 2.91) | 6.27 (5.20, 7.57) | <0.001 | |
| Smoker | 1739 | 1.00 | 1.65 (1.08, 2.52) | 1.99 (1.32, 3.01) | 4.22 (2.86, 6.23) | <0.001 | |
| Alcohol drinking status | 0.683 | ||||||
| Non-alcohol drinker | 6832 | 1.00 | 1.39 (1.11, 1.73) | 2.32 (1.89, 2.85) | 5.86 (4.80, 7.14) | <0.001 | |
| Alcohol drinker | 2657 | 1.00 | 1.71 (1.21, 2.41) | 2.38 (1.70, 3.33) | 5.83 (4.21, 8.05) | <0.001 | |
| WC2, cm | 0.165 | ||||||
| < 90 or 80 | 5044 | 1.00 | 1.44 (1.13, 1.84) | 2.59 (2.04, 3.28) | 5.66 (4.45, 7.19) | <0.001 | |
| ≥ 90 or 80 | 4445 | 1.00 | 1.57 (1.18, 2.09) | 2.24 (1.72, 2.93) | 6.27 (4.87, 8.09) | <0.001 | |
| WHtR | 0.170 | ||||||
| ≤ 0.5 | 3781 | 1.00 | 1.43 (1.07, 1.92) | 2.93 (2.21, 3.89) | 7.02 (5.24, 9.42) | <0.001 | |
| > 0.5 | 5708 | 1.00 | 1.48 (1.16, 1.89) | 2.07 (1.65, 2.60) | 5.40 (4.35, 6.69) | <0.001 | |
| BMI, kg/m2 | 0.599 | ||||||
| < 24 | 5458 | 1.00 | 1.54 (1.22, 1.96) | 2.69 (2.14, 3.38) | 6.31 (5.05, 7.89) | <0.001 | |
| ≥ 24 | 4031 | 1.00 | 1.40 (1.04, 1.89) | 2.19 (1.66, 2.89) | 6.04 (4.65, 7.84) | <0.001 | |
| BFP3, % | 0.709 | ||||||
| ≤ 25 or 30 | 3469 | 1.00 | 1.54 (1.16, 2.07) | 2.42 (1.81, 3.22) | 6.10 (4.62, 8.07) | <0.001 | |
| > 25 or 30 | 4927 | 1.00 | 1.46 (1.11, 1.92) | 2.35 (1.82, 3.03) | 6.26 (4.91, 7.99) | <0.001 | |
Odds ratios and 95% CIs of T2D by quartiles of TyG index stratified by covariates1.
1 Adjusted for age (continuous) and sex (men, women), education levels (less than high school, high school, college or above), occupation (light, medium, heavy physical labor), smoking status (smoker, non-smoker), alcohol drinking (alcohol drinker, non-alcohol drinker) and BMI (continuous). Stratified factors were not included in the corresponding models. 2 Cut-off points of WC were 90 cm for men and 80 cm for women. 3 Cut-off points of BFP were 25% for men and 30% for women.
CI, confidence interval; T2D, type 2 diabetes; TyG index, triglyceride-glucose index; Q1, first quartile; Q2, second quartile; Q3, third quartile; Q4, fourth quartile; WC, waist circumference; WHtR, waist-to-height ratio; BMI, body mass index; BFP, body fat percentage.
3.5 The predictive value of TyG index, obesity-related TyG indices for T2D
ROC curve for TyG and obesity-related TyG indices were presented in Figure 2. TyG had the highest area under the curve (AUC = 0.722, 95% CI: 0.709–0.736), followed by TyG-WHtR (0.711, 95% CI: 0.697–0.724), TyG-WC (0.705, 95% CI: 0.691–0.719), TyG-BMI (0.683, 95% CI: 0.669–0.698) and TyG-BFP (0.631, 95% CI: 0.616–0.646). As for impaired glucose metabolism, similar results were observed in Supplementary Figure S1, with the AUC of 0.682 (95% CI: 0.669–0.696), 0.682 (95% CI: 0.668–0.695), 0.673 (95% CI: 0.659–0.686), 0.665 (95% CI: 0.651–0.678) and 0.614 (95% CI: 0.600–0.628) for TyG, TyG-WHtR, TyG-WC, TyG-BMI and TyG-BFP, respectively.
Figure 2
4 Discussion
In this representative cross-sectional study with 9,489 middle-aged and older Chinese adults, we delved into the corrections between T2D risk and both TyG index and obesity-related TyG indices. We observed that TyG index, as well as TyG-BMI, TyG-WC, TyG-WHtR and TyG-BFP, were positively associated with risk of T2D. These associations persisted even after accounting for potential confounders. Positive associations between TyG index, obesity-related TyG indices and FPG, OGTT 2h-PG and HbA1c were also found. In addition, TyG index had the higher predictive ability for T2D, followed by abdominal obesity-related TyG indices (TyG-WHtR and TyG-WC), and general obesity-related TyG indices (TyG-BMI and TyG-BFP).
A majority of previous researches have examined the associations between the TyG index and disorder glucose metabolism, including prediabetes and diabetes. In a cross-sectional study conducted in representative American adults, in comparison to the bottom group, participants with higher TyG index were associated with the higher risk of both prediabetes and diabetes (). Another prospective cohort study undertaken in Japan also demonstrated a positive correction between TyG index and the risk of T2D (). In the Chinese population, several studies conducted in geriatric (, ), rural area (), or general individuals () found consistently that increasing TyG index was related with the higher incidence risk of prediabetes and diabetes. The above results revealed that TyG index served as a potential marker or predictor of risk of both prediabetes and T2D. Corresponding with these studies, the current investigation also observed a positive relationship between TyG index and T2D, as well as impaired glucose metabolism. Disorder of glucose and lipid metabolism was an crucial cause for diabetes. The increase of glucose and TG levels disrupted the function of pancreatic islet β cells through elevating reactive oxygen, inflammation, endoplasmic reticulum stress and ectopic fat deposition, therefore resulting to pancreatic dysfunction and insulin resistance (–). Therefore, the TyG index could be a complex and effective indicator to reflect diabetes or disorder of glucose metabolism, which aligned with the description of the present and previous researches mentioned above.
Obesity was another important and modifiable risk factor for diabetes. It was reported that obesity accounted for 52.2% of the disability-adjusted life-years (DALYs) linked to T2D in 2021, with a more than 20% increase since 1990 (), which emphasized its significant impact on T2D. The existing studies have examined the relationships between T2D and obesity-related TyG indices, such as TyG-BMI, TyG-WC and TyG-WHtR (–). BMI was the most common indicator for measuring general obesity, and many studies combined it with the TyG index to investigate the correction between obesity-related TyG indices and impaired glucose metabolism. TyG-BMI was discovered to be associated with the risk of T2D, whatever prediabetes or general individuals from people of different ethnic groups (, –). Moreover, reduction of TyG-BMI via active management was possible to help to convert prediabetes into normoglycemia (, ). Body fat was additionally another indicator on behalf of general obesity, however, there was a paucity of studies that addressed the interaction of TyG index and body fat on T2D. In the present research, we found that the TyG-BFP index, the product of TyG and BFP, was as important as other effective obesity-indicator to predict T2D and impaired glucose metabolism. In regard to abdominal obesity, the latest research have found that general and abdominal adiposity could discriminate people with or without hypertension (), which suggested that the abdominal adiposity, usually described by WC and WHtR, may be as a important risk factor as the general adiposity to diabetes. As the findings from previous studies shown, TyG-WC and TyG-WHtR were also effective markers to identify the diabetes risk (, ). Furthermore, they seem to be better indicators for predicting prediabetes in Indian () and Qatari () population in Asia. In this study, significant positive corrections were found between TyG-WC, TyG-WHtR, and risk of T2D and impaired glucose metabolism. TyG-WC and TyG-WHtR demonstrated superior predictive efficacy for diabetes than TyG-BMI and TyG-BFP, which were aligned with the previous findings.
Our study boasts notable strengths. It was undertaken in a representative, community-dwelling population with a wide range of age (equal or more than 40 years) in China. It was also a frontier research to combine different phenotypes of obesity, including general and abdominal obesity, with TyG index to discuss the relationship between obesity-related TyG indices and T2D, and compared their predictive value ulteriorly.
Several limitations need to be considered in our study. First, despite our efforts to adjust to potential risk factors, residual confounding cannot be eradicated fully. Moreover, the cross-sectional design constrained our ability to definitively rule out the possibility that reverse causality and residual confounding may have skewed our findings. Further prospective or interventional researches were required to solidify our understanding of associations between obesity-related TyG parameters and diabetes.
5 Conclusions
In conclusion, positive associations were observed between TyG index, as well as obesity-related TyG indices including TyG-BMI, TyG-WC, TyG-WHtR and TyG-BFP, and risk of T2D. Abdominal obesity-related TyG index had enhanced predictive value to diabetes than general obesity-related TyG index. Further large prospective researches were required to validate our findings.
Statements
Data availability statement
The data analyzed in this study is subject to the following licenses/restrictions: Data described in the article are available from the corresponding author upon reasonable request. Requests to access these datasets should be directed to Li Yan, yanli@mail.sysu.edu.cn.
Ethics statement
The studies involving humans were approved by the Ethical Committee of Sun Yat-sen Memorial Hospital of Sun Yat-sen University and Ruijin Hospital Ethics Committee of Shanghai Jiao Tong University School of Medicine. The studies were conducted in accordance with the local legislation and institutional requirements. The participants provided their written informed consent to participate in this study.
Author contributions
XTL: Conceptualization, Data curation, Formal analysis, Investigation, Methodology, Software, Writing – original draft. SC: Data curation, Investigation, Methodology, Validation, Writing – review & editing. CW: Funding acquisition, Investigation, Validation, Writing – review & editing. DL: Funding acquisition, Investigation, Project administration, Writing – review & editing. FH: Investigation, Writing – review & editing. XHL: Investigation, Writing – review & editing. HW: Investigation, Writing – review & editing. PL: Investigation, Writing – review & editing. LY: Conceptualization, Funding acquisition, Project administration, Supervision, Visualization, Writing – review & editing. MR: Conceptualization, Funding acquisition, Project administration, Supervision, Visualization, Writing – review & editing. CC: Conceptualization, Funding acquisition, Project administration, Supervision, Visualization, Writing – review & editing.
Funding
The author(s) declare that financial support was received for the research and/or publication of this article. This work was jointly funded by the National key research & development plan of China, major project of prevention and treatment for common diseases (2022YFC2505300, subproject: 2022YFC2505304), National Natural Science Foundation of China (U20A20352, 82370822, 82470850, 82373552, 82100890), Guangdong Clinical Research Center for Metabolic Diseases (2020B1111170009), Guangdong Basic and Applied Basic Research Foundation (2024A1515010503) and Guangzhou Science and technology projects (2024B03J1342, 2023A04J2115).
Acknowledgments
The authors thank all of the volunteers, staff, and partner organizations participating in this study.
Conflict of interest
The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.
Generative AI statement
The author(s) declare that no Generative AI was used in the creation of this manuscript.
Publisher’s note
All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article, or claim that may be made by its manufacturer, is not guaranteed or endorsed by the publisher.
Supplementary material
The Supplementary Material for this article can be found online at: https://www.frontiersin.org/articles/10.3389/fendo.2025.1526849/full#supplementary-material
Glossary
- T2D
type 2 diabetes
- TyG index
triglyceride-glucose index
- TG
triglyceride
- FPG
fasting plasma glucose
- HOMA-IR
homeostatic model assessment of insulin resistance
- BMI
body mass index
- BFP
body fat percentage
- WC
waist circumference
- WHtR
waist-to-height ratio
- REACTION study
the Risk Evaluation of cAncers in Chinese diabeTic Individuals, A lONgitudinal study
- OGTT 2h-PG
oral glucose tolerance test 2 h plasma glucose
- HbA1c
glycated hemoglobin
- FINS
fasting serum insulin
- TC
total cholesterol
- HDL-C
high-density lipoprotein cholesterol
- LDL-C
low-density lipoprotein cholesterol
- Q1
first quartile
- Q2
second quartile
- Q3
third quartile
- Q4
fourth quartile
- SD
standard deviation
- OR
odds ratio
- CI
confidence interval
- ROC
receiver operating characteristic
- SE
standard error
- AUC
area under the curve
- NHANES
National Health and Nutrition Examination Survey
- NAGALA
NAfld in the Gifu Area, Longitudinal Analysis
- DALYs
disability-adjusted life-years
References
1
World Health Organization. Diabetes . Available online at: https://www.who.int/news-room/fact-sheets/detail/diabetes (Accessed November 12, 2024).
2
International Diabetes Federation. IDF Diabetes Atlas. 10th. Brussels, Belgium: International Diabetes Federation (2021). Available at: https://www.diabetesatlas.org/en/.
3
WalfordGAMaYClishCFlorezJCWangTJGersztenREet al. Metabolite profiles of diabetes incidence and intervention response in the diabetes prevention program. Diabetes. (2016) 65:1424–33. doi: 10.2337/db15-1063
4
XuanXHamaguchiMCaoQOkamuraTHashimotoYOboraAet al. U-shaped association between the triglyceride-glucose index and the risk of incident diabetes in people with normal glycemic level: A population-base longitudinal cohort study. Clin Nutr. (2021) 40:1555–61. doi: 10.1016/j.clnu.2021.02.037
5
WenJWangALiuGWangMZuoYLiWet al. Elevated triglyceride-glucose (TyG) index predicts incidence of Prediabetes: a prospective cohort study in China. Lipids Health Dis. (2020) 19:226. doi: 10.1186/s12944-020-01401-9
6
ChenZWenJ. Elevated triglyceride-glucose (TyG) index predicts impaired islet β-cell function: A hospital-based cross-sectional study. Front Endocrinol (Lausanne). (2022) 13:973655. doi: 10.3389/fendo.2022.973655
7
MassiminoMMoneaGMarinaroGRubinoMMancusoEManninoGCet al. The triglycerides and glucose (TyG) index is associated with 1-hour glucose levels during an OGTT. Int J Environ Res Public Health. (2022) 20:787. doi: 10.3390/ijerph20010787
8
LuoPCaoYLiPLiWSongZFuZet al. TyG index performs better than HOMA-IR in chinese type 2 diabetes mellitus with a BMI < 35 kg/m2: A hyperglycemic clamp validated study. Med (Kaunas). (2022) 58:876. doi: 10.3390/medicina58070876
9
ZhangMWangBLiuYSunXLuoXWangCet al. Cumulative increased risk of incident type 2 diabetes mellitus with increasing triglyceride glucose index in normal-weight people: The Rural Chinese Cohort Study. Cardiovasc Diabetol. (2017) 16:30. doi: 10.1186/s12933-017-0514-x
10
WangZZhaoLHeS. Triglyceride-glucose index as predictor for future type 2 diabetes mellitus in a Chinese population in southwest China: a 15-year prospective study. Endocrine. (2021) 72:124–31. doi: 10.1007/s12020-020-02589-7
11
WangBZhangMLiuYSunXZhangLWangCet al. Utility of three novel insulin resistance-related lipid indices for predicting type 2 diabetes mellitus among people with normal fasting glucose in rural China. J Diabetes. (2018) 10:641–52. doi: 10.1111/jdb.2018.10.issue-8
12
CybulskaAMSchneider-MatykaDWieder-HuszlaSPanczykMJurczakAGrochansE. Diagnostic markers of insulin resistance to discriminate between prediabetes and diabetes in menopausal women. Eur Rev Med Pharmacol Sci. (2023) 27:2453–68. doi: 10.26355/eurrev_202303_31779
13
ChamroonkiadtikunPAnanchaisarpTWanichanonW. The triglyceride-glucose index, a predictor of type 2 diabetes development: A retrospective cohort study. Prim Care Diabetes. (2020) 14:161–7. doi: 10.1016/j.pcd.2019.08.004
14
Darshan AnVRajputRMeenaMohiniGargRSainiS. Comparison of triglyceride glucose index and HbA1C as a marker of prediabetes - A preliminary study. Diabetes Metab Syndr. (2022) 16:102605. doi: 10.1016/j.dsx.2022.102605
15
NCD Risk Factor Collaboration. General and abdominal adiposity and hypertension in eight world regions: a pooled analysis of 837 population-based studies with 7.5 million participants. Lancet. (2024) 404:851–63. doi: 10.1016/S0140-6736(24)01405-3
16
MainaJGPascatVZudinaLUlrichAPupkoIBonnefondAet al. Abdominal obesity is a more important causal risk factor for pancreatic cancer than overall obesity. Eur J Hum Genet. (2023) 31:962–6. doi: 10.1038/s41431-023-01301-3
17
ZhengSShiSRenXHanTLiYChenYet al. Triglyceride glucose-waist circumference, a novel and effective predictor of diabetes in first-degree relatives of type 2 diabetes patients: cross-sectional and prospective cohort study. J Transl Med. (2016) 14:260. doi: 10.1186/s12967-016-1020-8
18
XuanWLiuDZhongJLuoHZhangX. Impacts of triglyceride glucose-waist to height ratio on diabetes incidence: A secondary analysis of A population-based longitudinal data. Front Endocrinol (Lausanne). (2022) 13:949831. doi: 10.3389/fendo.2022.949831
19
WangXLiuJChengZZhongYChenXSongW. Triglyceride glucose-body mass index and the risk of diabetes: a general population-based cohort study. Lipids Health Dis. (2021) 20:99. doi: 10.1186/s12944-021-01532-7
20
BiYLuJWangWMuYZhaoJLiuCet al. Cohort profile: risk evaluation of cancers in Chinese diabetic individuals: a longitudinal (REACTION) study. J Diabetes. (2014) 6:147–57. doi: 10.1111/jdb.2014.6.issue-2
21
NingG. Risk Evaluation of cAncers in Chinese diabeTic Individuals: a lONgitudinal (REACTION) study. J Diabetes. (2012) 4:172–3. doi: 10.1111/j.1753-0407.2012.00182.x
22
LiHZuoYQianFChenSTianXWangPet al. Triglyceride-glucose index variability and incident cardiovascular disease: a prospective cohort study. Cardiovasc Diabetol. (2022) 21:105. doi: 10.1186/s12933-022-01541-5
23
SongKParkGLeeHSLeeMLeeHIChoiHSet al. Comparison of the triglyceride glucose index and modified triglyceride glucose indices to predict nonalcoholic fatty liver disease in youths. J Pediatr. (2022) 242:79–85 e1. doi: 10.1016/j.jpeds.2021.11.042
24
American Diabetes Association. Diagnosis and classification of diabetes mellitus. Diabetes Care. (2014) 37:S81–90. doi: 10.2337/dc14-S081
25
ZhangLZengL. Non-linear association of triglyceride-glucose index with prevalence of prediabetes and diabetes: a cross-sectional study. Front Endocrinol (Lausanne). (2023) 14:1295641. doi: 10.3389/fendo.2023.1295641
26
LiuEQWengYPZhouAMZengCL. Association between triglyceride-glucose index and type 2 diabetes mellitus in the Japanese population: A secondary analysis of a retrospective cohort study. BioMed Res Int. (2020) 2020:2947067. doi: 10.1155/2020/2947067
27
FuXLiuHLiuJLiNLiLKeDet al. Association between triglyceride-glucose index and the risk of type 2 diabetes mellitus in an older chinese population aged over 75 years. Front Public Health. (2021) 9:796663. doi: 10.3389/fpubh.2021.796663
28
HeLZhengWLiZKongWZengT. Association of four lipid-derived indicators with the risk of developing type 2 diabetes: a Chinese population-based cohort study. Lipids Health Dis. (2023) 22:24. doi: 10.1186/s12944-023-01790-7
29
SondergaardENielsenS. VLDL triglyceride accumulation in skeletal muscle and adipose tissue in type 2 diabetes. Curr Opin Lipidol. (2018) 29:42–7. doi: 10.1097/MOL.0000000000000471
30
ZhouMZhuLCuiXFengLZhaoXHeSet al. The triglyceride to high-density lipoprotein cholesterol (TG/HDL-C) ratio as a predictor of insulin resistance but not of beta cell function in a Chinese population with different glucose tolerance status. Lipids Health Dis. (2016) 15:104. doi: 10.1186/s12944-016-0270-z
31
LiXSunMYangYYaoNYanSWangLet al. Predictive effect of triglyceride glucose-related parameters, obesity indices, and lipid ratios for diabetes in a chinese population: A prospective cohort study. Front Endocrinol (Lausanne). (2022) 13:862919. doi: 10.3389/fendo.2022.862919
32
LuXXieQPanXZhangRZhangXPengGet al. Type 2 diabetes mellitus in adults: pathogenesis, prevention and therapy. Signal Transduct Target Ther. (2024) 9:262. doi: 10.1038/s41392-024-01951-9
33
GBD 2021 Diabetes Collaborators. Global, regional, and national burden of diabetes from 1990 to 2021, with projections of prevalence to 2050: a systematic analysis for the Global Burden of Disease Study 2021. Lancet. (2023) 402:203–34. doi: 10.1016/S0140-6736(23)01301-6
34
HanYHuHLiQDengZLiuD. Triglyceride glucose-body mass index and the risk of progression to diabetes from prediabetes: A 5-year cohort study in Chinese adults. Front Public Health. (2023) 11:1028461. doi: 10.3389/fpubh.2023.1028461
35
Navarro-GonzálezDSánchez-ÍñigoLFernández-MonteroAPastrana-DelgadoJMartinezJA. TyG index change is more determinant for forecasting type 2 diabetes onset than weight gain. Med (Baltimore). (2016) 95:e3646. doi: 10.1097/MD.0000000000003646
36
LowSKhooKCJIrwanBSumCFSubramaniamTLimSCet al. The role of triglyceride glucose index in development of Type 2 diabetes mellitus. Diabetes Res Clin Pract. (2018) 143:43–9. doi: 10.1016/j.diabres.2018.06.006
37
SongBZhaoXYaoTLuWZhangHLiuTet al. Triglyceride glucose-body mass index and risk of incident type 2 diabetes mellitus in Japanese people with normal glycemic level: A population-based longitudinal cohort study. Front Endocrinol (Lausanne). (2022) 13:907973. doi: 10.3389/fendo.2022.907973
38
YangHKuangMQiuJHeSYuCShengGet al. Relative importance of triglyceride glucose index combined with body mass index in predicting recovery from prediabetic state to normal fasting glucose: a cohort analysis based on a Chinese physical examination population. Lipids Health Dis. (2024) 23:71. doi: 10.1186/s12944-024-02060-w
39
ShaoYHuHCaoCHanYWuC. Elevated triglyceride-glucose-body mass index associated with lower probability of future regression to normoglycemia in Chinese adults with prediabetes: a 5-year cohort study. Front Endocrinol (Lausanne). (2024) 15:1278239. doi: 10.3389/fendo.2024.1278239
40
Ramdas NayakVKNayakKRVidyasagarSPR. Predictive performance of traditional and novel lipid combined anthropometric indices to identify prediabetes. Diabetes Metab Syndr. (2020) 14:1265–72. doi: 10.1016/j.dsx.2020.06.045
41
Al AklNSHaoudiENBensmailHArredouaniA. The triglyceride glucose-waist-to-height ratio outperforms obesity and other triglyceride-related parameters in detecting prediabetes in normal-weight Qatari adults: A cross-sectional study. Front Public Health. (2023) 11:1086771. doi: 10.3389/fpubh.2023.1086771
Summary
Keywords
triglyceride-glucose index, obesity-related TyG indices, type 2 diabetes, abdominal obesity, middle-aged and older Chinese adults, cross-sectional study
Citation
Lu X, Chen S, Wang C, Lin D, He F, Lin X, Wu H, Liang P, Yan L, Ren M and Chen C (2025) Stronger associations of abdominal obesity-related triglyceride-glucose indices with type 2 diabetes compared to general obesity-related indices in community-dwelling Chinese adults: a cross-sectional study. Front. Endocrinol. 16:1526849. doi: 10.3389/fendo.2025.1526849
Received
12 November 2024
Accepted
05 May 2025
Published
10 June 2025
Volume
16 - 2025
Edited by
Evan P. Nadler, George Washington University, United States
Reviewed by
Nikhil Suresh Bhandarkar, Narayana Nethralaya Eye Hospital, India
Arzu Or Koca, Dr. Abdurrahman Yurtaslan Ankara Oncology Training and Research Hospital, Türkiye
Updates
Copyright
© 2025 Lu, Chen, Wang, Lin, He, Lin, Wu, Liang, Yan, Ren and Chen.
This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
*Correspondence: Li Yan, yanli@mail.sysu.edu.cn; Meng Ren, renmeng@mail.sysu.edu.cn; Chaogang Chen, chenchg@mail.sysu.edu.cn
†These authors have contributed equally to this work
Disclaimer
All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.